Search results
Agathos Biologics aims for ethical solutions in gene therapy, including morally derived vaccines
The Fargo Forum· 4 days agoFor Andrzej Noyszewski, the most mundane drive to work often elicits a deep sense of gratitude....
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning
Investing.com· 15 hours agoStrong demand was seen for the ExoDx Prostate test and Comet platform, with the latter expected to...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia - Pfizer (NYSE:PFE)
Benzinga· 6 days agoFriday, the FDA approved Pfizer Inc’s PFE Beqvez (fidanacogene elaparvovec-dzkt) for moderate to...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days ago“I look forward to sharing more about my clinical experience with this novel modifier gene therapy with my peers and industry leadership during the summit ...
Autism Spectrum Disorder (ASD)
Health via Yahoo News· 1 hour agoAutism spectrum disorder (ASD) is a neurodevelopmental condition that causes brain differences that can affect your emotions, behavior, and social...
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning By Investing.com
Investing.com· 19 hours agoStrong demand was seen for the ExoDx Prostate test and Comet platform, with the latter expected to...
Senti Biosciences reports breakthrough in AML treatment By Investing.com
Investing.com· 2 days agoThis data, which was recently published in the journal Cell Reports, highlights the ability of...
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on...
BioPharma-Reporter· 2 days agoAlmost half of all strategic alliances focused on RNA therapies over the last five years in the...
New gene signature could transform immunotherapy for gastrointestinal cancers
Medical Xpress· 2 days agoDespite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy, and targeted therapy, the objective response ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoIt's important to note that shares are not forming a chart pattern for investors to watch. On April...